96 related articles for article (PubMed ID: 609635)
1. [Prognostic value of PPD test in patients with bronchial carcinoma treated by BCG vaccine (author's transl)].
Jakasa D
Plucne Bolesti Tuberk; 1977; 29(3-4):265-8. PubMed ID: 609635
[No Abstract] [Full Text] [Related]
2. A pilot study on the effect of BCG vaccination in patients with bronchial carcinoma.
Nilsson BS; Afeldt PE
Scand J Respir Dis; 1975 Aug; 56(2):84-6. PubMed ID: 1172630
[TBL] [Abstract][Full Text] [Related]
3. [Immunological state of patients with malignant tumor of the bronchi and lung examined by PPD test (author's transl)].
Grbac I; Basić-Grbac M; Jakasa D; Mulhim M
Plucne Bolesti Tuberk; 1978; 30(4):324-8. PubMed ID: 752820
[No Abstract] [Full Text] [Related]
4. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
Bilen CY; Inci K; Erkan I; Ozen H
J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
Jansen HM; The TH; Orie NG
Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
[TBL] [Abstract][Full Text] [Related]
6. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
[TBL] [Abstract][Full Text] [Related]
7. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG (author's transl)].
Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Vilcoq JR; Bataini JP; Calle R; Fenton J; Mathieu G; Rousseau J; Asselain B
Bull Cancer; 1981; 68(2):171-86. PubMed ID: 7016224
[TBL] [Abstract][Full Text] [Related]
11. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
[No Abstract] [Full Text] [Related]
12. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG.
Anthony HM; Kirk JA; Madsen KE; Mason MK; Templeman GH
Clin Exp Immunol; 1975 Apr; 20(1):41-54. PubMed ID: 54235
[TBL] [Abstract][Full Text] [Related]
13. Mucosal melanoma. Immunological findings in a rare case treated with BCG vaccine, autologous tumor cells, and cytarabine.
Edström S; Jacobsson S; Jeppsson PH
Arch Otolaryngol; 1979 Jan; 105(1):48-50. PubMed ID: 760707
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy with BCG and mycobacterial fractions and its use in bronchogenic carcinoma (author's transl)].
Brehmer W; Huckauf H; Ribi E
Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():358-65. PubMed ID: 461310
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
[No Abstract] [Full Text] [Related]
16. Delayed hypersensitivity in patients with bronchial carcinoma.
Pauwels R; van der Straeten M
Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
[TBL] [Abstract][Full Text] [Related]
17. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG.
Stack BH; McSwan N; Stirling JM; Hole DJ; Parratt D; Spilg WG; Gillis CR; McHattie I; Green AG; White RG; Turner MA
Thorax; 1979 Feb; 34(1):68-73. PubMed ID: 442002
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of DHS skin tests in patients with carcinoma of bronchus.
Anthony HM; Templeman GH; Madsen KE; Mason MK
Cancer; 1974 Dec; 34(6):1901-6. PubMed ID: 4373163
[No Abstract] [Full Text] [Related]
20. [Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
Flamm J; Grof F
Wien Med Wochenschr; 1981 Oct; 131(20):501-6. PubMed ID: 7314632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
